Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-084560

Options or other derivatives

  • Director acquired 4,595 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Coleman Mark Director 2025-06-06 Grant or award · Stock Option (Right to Buy) +3,166 3,166 D
Coleman Mark Director 2025-06-06 Grant or award · Restricted Stock Units +1,429 1,429 D
Loading xslF345X05/ownership.xml…